Advertisement

Topics

MediPoint: Viscosupplementation North America Analysis and Market Forecasts [Updated: 01042017] Prices from USD $5000

11:07 EDT 21 Jun 2017 | BioPortfolio Report Blog

MediPoint: Viscosupplementation North America Analysis and Market Forecasts

Summary

Osteoarthritis OA constitutes a growing public health burden, and is the most common cause of musculoskeletal disability around the world. Resulting from a complex interaction of biomechanical, biochemical, and genetic factors, OA develops slowly and is characterized by the degradation of the affected joint's cartilage and bone hypertrophy. The disability is accompanied by joint pain, stiffness, and loss of range of motion. Initially treated with various therapies including physical therapy and nonsteroidal antiinflammatory drugs NSAIDs, advanced cases of OA have traditionally been treated surgically. However, intraarticular viscosupplementation with hyaluronic acid HA, a highmolecularweight glycosaminoglycan, has become an increasingly accepted therapeutic alternative to knee replacement surgery in the symptomatic management of OA over the past decade.

This report focuses on the market outlook for viscosupplementation products in North America Canada, Mexico, and US. The analysis discusses the major drivers and barriers of adoption, and provides an indepth understanding of the future outlook for this market by segment and geography.

Key Questions Answered

What is the current and future viscosupplementation market outlook in the developed and emerging markets? What trends are affecting the North American market?
Which are the key, high growth markets that viscosupplementation manufacturers should expand into? Which markets are growing the fastest, and what are the topselling products in each segment?
What are the unmet needs with the current generation of viscosupplementation products? How will emerging technologies fulfill these unmet needs?
What clinical factors and technical specifications influence a physician to use one type of device over another? What is physician perception and market outlook for viscosupplementation?
What are the challenges and complications that have hindered widespread adoption?
With developing the nextgeneration of devices, what aspects of the technology are device manufacturers focused on optimizing? How will new entrants impact the viscosupplementation market?

Scope

Overview of recent key industry events and analysis of their market impact.
Annualized total market revenue by type of device, procedure trends, and market outlooks by segment and by country through 2023.
Key topics covered include strategic competitor assessment, market characterization, and implications of the emerging technologies in the market.
Pipeline analysis: Comprehensive data split across different stages of development, including a discussion of emerging trends and devices in development.
Analysis of the current and future market competition in the North American viscosupplementation market. Insightful review of the key industry drivers, barriers, and challenges. Each trend is independently researched to provide qualitative analysis of its implications.

Reasons to buy

The report will enable you to
Develop and design your inlicensing and outlicensing strategies through a review of marketed products and technologies.
Develop business strategies by understanding the trends shaping and driving the viscosupplementation market.
Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the viscosupplementation market in the future.
Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the performance of various competitors.
Identify emerging players with potentially strong product portfolios and create effective counterstrategies to gain a competitive advantage.
Track device sales in countryspecific viscosupplementation markets from 20142023.
Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.

Original Article: MediPoint: Viscosupplementation North America Analysis and Market Forecasts [Updated: 01042017] Prices from USD $5000

NEXT ARTICLE

More From BioPortfolio on "MediPoint: Viscosupplementation North America Analysis and Market Forecasts [Updated: 01042017] Prices from USD $5000"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Arthritis
Arthritis is by definition the inflammation of one or more joints, characterized by swelling, pain, warmth, redness and diminished range of joint movement (Oxford Medical Dictionary). There are many different types; Noninflammatory; Osteoarthritis, N...

Public Health
Alternative Medicine Cleft Palate Complementary & Alternative Medicine Congenital Diseases Dentistry Ear Nose & Throat Food Safety Geriatrics Healthcare Hearing Medical Devices MRSA Muscular Dyst...

Rheumatology
Arthritis Fibromyalgia Gout Lupus Rheumatic Rheumatology is the medical specialty concerned with the diagnosis and management of disease involving joints, tendons, muscles, ligaments and associated structures (Oxford Medical Diction...